FBL and type 2 diabetes mellitus: The present study was designed to probe the prevalence of autoantibodies against MG-glycated fibrinogen (MG-Fib) in patients suffering from T2DM, atherosclerosis (ATH), and diabetic atherosclerosis (T2DM-ATH).